Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT04735965

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04735965
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04735965. Randomized; quadruple masking; primary purpose prevention. Start 2021-07-15 (actual); primary completion 2022-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft
Condition
Postoperative Shivering
Intervention (Drug)
Dexmedetomidine
Intervention (Drug)
Meperidine
Intervention (Drug)
Placeb
Lead sponsor
Qianfoshan Hospital (class: other)

Record details

Record id
cardio:ct-nct04735965
Content hash
5973e08be334b4263e491b03788b8ab55f44f0964c56397eed31b465021de341